MicroPort CardioFlow Medtech Corporation (02160) submitted its monthly return for the period ended 31 January 2026. The corporation maintained an authorized share capital of 10,000,000,000 ordinary shares, par value USD 0.000005 each, for a total of USD 50,000.

The total number of issued ordinary shares at the end of the month reached 6,366,557,195, increasing by 3,013 shares from the previous month. According to the report, the public float requirement was met. Share option exercises accounted for 3,013 newly issued shares, generating proceeds of HKD 3,736.12.

Under the share option scheme, the outstanding options stood at 54,084,131 following the exercise of 3,013 options. In a separate share scheme, 1,716,512 shares were canceled, leaving 24,388,550 options outstanding at month-end. No other movements in issued shares or treasury shares were reported.